Aclaris Therapeutics, Inc. (ACRS)
NASDAQ: ACRS · Real-Time Price · USD
5.47
-0.16 (-2.76%)
Jul 23, 2026, 12:19 PM EDT - Market open
Aclaris Therapeutics Market Cap
Aclaris Therapeutics has a market cap or net worth of $763.26 million as of July 23, 2026. Its market cap has increased by 335.12% in one year.
Market Cap
763.26M
Enterprise Value
596.11M
1-Year Change
335.12%
Ranking
Category
Stock Price
$5.47
ChartMarket Cap Chart
Since October 7, 2015, Aclaris Therapeutics's market cap has increased from $214.45M to $763.26M, an increase of 255.91%. That is a compound annual growth rate of 12.47%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 23, 2026 | 763.26M | 134.04% |
| Dec 31, 2025 | 326.12M | 22.88% |
| Dec 31, 2024 | 265.41M | 256.83% |
| Dec 29, 2023 | 74.38M | -92.92% |
| Dec 30, 2022 | 1.05B | 17.97% |
| Dec 31, 2021 | 890.25M | 220.59% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Odyssey Therapeutics | 841.70M |
| DBV Technologies | 839.30M |
| Solid Biosciences | 831.90M |
| Tenax Therapeutics | 801.12M |
| CytomX Therapeutics | 766.31M |
| Aura Biosciences | 752.24M |
| Neurogene | 744.07M |
| Design Therapeutics | 741.36M |